Patents by Inventor Mohammad Hossain

Mohammad Hossain has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 8298680
    Abstract: The solder composition comprises particles of a thermodynamically metastable alloy. One of the elements of the alloy will form an intermetallic compound with a metal surface. The solder composition is particularly suitable for use in bumping of semiconductor devices.
    Type: Grant
    Filed: May 11, 2005
    Date of Patent: October 30, 2012
    Assignees: Koninklijke Philips Electronics N.V., Mat-Tech B.V.
    Inventors: Nicolaas Johannes Anthonius Van Veen, Mohammad Hossain Biglari
  • Publication number: 20090162622
    Abstract: The solder composition comprises particles of a thermodynamically metastable alloy. One of the elements of the alloy will form an intermetallic compound with a metal surface. The solder composition is particularly suitable for use in bumping of semiconductor devices.
    Type: Application
    Filed: May 11, 2005
    Publication date: June 25, 2009
    Applicants: DUTCH POLYMER INSTITUTE, MAT-TECH B.V.
    Inventors: Nicolaas Johannes Anthonius Van Veen, Mohammad Hossain Biglari
  • Publication number: 20060073091
    Abstract: A direct low temperature process for lithiating hydroxides and forming lithiated transition metal oxides of suitable crystallinity. Elemental transition metal powders are combined with an aqueous solution of lithium hydroxide. The aqueous slurry solution is subject to oxidation. The resultant lithium transition metal oxide is crystallized in-situ and subsequently removed from the reactor.
    Type: Application
    Filed: October 1, 2004
    Publication date: April 6, 2006
    Inventors: Feng Zou, Mohammad Hossain
  • Publication number: 20050245459
    Abstract: A method of utilizing the physiological activity of a rare saccharide, wherein physiological-activity sensitive cells are treated with the rare saccharide to modify the function of the cells. A composition containing, as an active ingredient, a rare saccharide which is introduced into physiological-activity sensitive cells and has an effect of modifying the function of the cells. The cells are human cells. The composition is a functional food, a drug, or a cosmetic. The rare saccharide is a rare saccharide belonging to aldose and/or ketose. The aldose is D-allose, and the cells are selected from the group consisting of cancer-cell proliferation inhibitory activity sensitive cells and active-oxygen production inhibitory activity sensitive cells. The ketose is D-psicose, and the cells are selected from the group consisting of chemokine secretion inhibitory activity sensitive cells, microglia migration inhibitory activity sensitive cells, and hypoglycemic activity sensitive cells.
    Type: Application
    Filed: May 22, 2003
    Publication date: November 3, 2005
    Applicants: Fushimi Pharmaceutical Co. Ltd., Teikoku Seiyaku Co. Ltd., Kagawa University, Shikoku Research Institute Incorporated, Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo
    Inventors: Ken Izumori, Masaaki Tokuda, Toshifumi Itano, Osamu Miyamoto, Toshihiko Ishida, Koji Murao, Taizo Tasaka, Gan Muneuchi, Fuminori Yamaguchi, Terukazu Tanaka, Masaaki Ueki, Kazuyuki Hirooka, Tomohiko Taminato, Mohammad Hossain, Keiji Tsusaki, Takeo Takahashi, Mitsuhiro Nagata, Yutaka Ishida